Ocular Therapeutix Inc

NASDAQ:OCUL   3:59:35 PM EDT
10.28
+0.03 (+0.29%)
Products, Regulatory

Ocular Therapeutix Announces Topline Phase 1 Clinical Trial Results Of Otx-Csi

Published: 10/08/2020 13:06 GMT
Ocular Therapeutix Inc (OCUL) - Ocular Therapeutix™ Announces Topline Phase 1 Clinical Trial Results of Otx-csi.
Ocular Therapeutix Inc - Otx-csi Demonstrates Improvement in Signs and Symptoms of Dry Eye Disease.
Ocular Therapeutix Inc - Inserts Were Observed to Be Well-tolerated in Phase 1 Trial.
Ocular Therapeutix Inc - No Serious Adverse Effects Were Reported in Topline Phase 1 Clinical Trial Results of Otx-csi.